Northwest Biotherapeutics Inc. (NASDAQOTCBB:NWBO.OB)

CAPS Rating 1 out of 5 
NWBO.OB VS S&P 500 (SPY)

Related News and Articles

This ticker is not currently Ratable.

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

4 Outperform
27 Underperform
 

All-Star Players

1 Outperform
25 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

NWBO.OB Summary

Top NWBO.OB Bull/Bear Pitches

zzlangerhans (99.67)
Submitted October 20, 2011

Make no mistake. Northwest Biotherapeutics is a terrible, unscrupulous company that wouldn't hesitate twice to mislead investors and desperate patients alike. I wouldn't invest in Northwest if I knew the share price would double the next day. But… More

Fools bullish on NWBO.OB
are also bullish on:

zzlangerhans (99.67)
Submitted May 20, 2011

Looks like Northwest has been rescued from the unratable zone by yet another putrid PR flog from BioMedReports, based on the recent announcement that DCVax will be manufactured by the Fraunhofer Institute in Europe. Here's Garza:"Despite what anyone… More

Fools bearish on NWBO.OB
are also bearish on:

Featured Broker Partners


Advertisement